Head-to-Head diabetes drug trial aims for better daily control
NCT ID NCT06671587
Summary
This study aims to see which of two injectable diabetes medications works better at keeping blood sugar in a healthy range throughout the day. It will involve about 678 Chinese adults with type 2 diabetes whose blood sugar is not well controlled with pills alone. Participants will be randomly assigned to receive one of the two medications for 20 weeks, and their blood sugar will be monitored continuously with a wearable device to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number: 1560001
RECRUITINGBeijing, 100730, China
Conditions
Explore the condition pages connected to this study.